Study of Fexuclu tablets for stomach inflammation (gastritis)
Part of Digestive system, Immune system & allergy, Lungs & breathing clinical trials.
This study watches patients with acute or chronic gastritis who are already being prescribed the stomach medicine Fexuclu (fexuprazan). It collects information to see how well the medicine works and if it causes any side effects in everyday use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 75 years old.
- Your doctor plans to prescribe Fexuclu tablets (fexuprazan) for your stomach condition.
- You have at least one stomach symptom, like pain, burning, or nausea, that needs treatment.
- You understand the study and agree to let the researchers use your medical data.
- You do not have any medical reason that would make fexuprazan unsafe for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medication called Sto M Tab helps people with acute or chronic gastritis (stomach lining inflammation). You must have had recent endoscopy confirming stomach erosions to join.
This trial tests whether a medication called Fexuclue can protect your stomach when you take NSAIDs (common pain relievers like ibuprofen or naproxen). If you need to take NSAIDs regularly, this study looks at how well Fexuclue prevents painful stomach ulcers in everyday practice.
This study tests whether a medication called fexuprazan can protect your stomach from ulcers while you take NSAIDs (common pain relievers like ibuprofen) for ongoing joint or muscle problems. The trial checks if it's safe and works better than standard care.
This trial tests whether fexuprazan can prevent upper gastrointestinal bleeding in people at high risk who need two antiplatelet drugs for at least 6 months after a heart stent. If you are on dual antiplatelet therapy after a stent and have risk factors like older age, low weight, or history of ulcers, this study may help protect your stomach.
This trial tests whether fexuprazan can help prevent stomach bleeding in people with atrial fibrillation who take blood thinners like apixaban or rivaroxaban. If you are at higher risk for stomach bleeding, this study may offer extra protection.
This trial tests how the body processes a new tablet called IN-M00002, and how food affects its absorption. It is for healthy volunteers to help find the right dose and understand side effects.
Hear when a new Gastritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.